Arrowhead Regional Medical Center

Arrowhead Regional Medical Center was paid $145.44M by Medicaid between Jan 2018 and Dec 2024, across 823 billing codes. Its largest line is 0510, — 5.0% of everything it billed.

33Billing provider infoARROWHEAD REGIONAL MEDICAL CENTER
COLTON, CA 92324

33aNPI1043380330assigned 11/08/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$145.44M

24GClaims7,250,760

24DCodes billed823

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in California

Rank by total paid#9 of 410

Median peer was paid$6.90M

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	837,375	$16.46M
2019	931,421	$20.89M
2020	816,443	$17.68M
2021	1,068,385	$19.32M
2022	997,209	$18.50M
2023	1,342,315	$26.02M
2024incomplete	1,257,612	$26.57M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
0510		5.0%	419,252	320,453	$7.21M
90999	Dialysis (unlisted procedure)Unlisted dialysis procedure, inpatient or outpatient	4.9%	54,573	4,545	$7.10M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	4.8%	337,632	261,352	$7.00M
0450	Emergency room services	4.8%	135,213	117,965	$6.91M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.4%	97,730	83,492	$4.97M
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	2.6%	10,893	10,581	$3.74M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.1%	17,289	16,425	$2.99M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	2.0%	3,542	3,383	$2.90M
99070		1.8%	220,800	102,489	$2.55M
70450	Computed tomography, head or brain; without contrast material	1.7%	16,917	16,095	$2.46M
Z7502		1.4%	55,410	54,820	$2.08M
J9035	Injection, bevacizumab, 10 mg	1.4%	1,737	1,304	$2.07M

811 more codes

77067	Screening mammography, bilateral, including computer-aided detection	1.3%	21,246	$1.88M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.3%	12,344	$1.84M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	1.3%	211,969	$1.82M
80053	Comprehensive metabolic panel	1.2%	179,298	$1.77M
Z7500		1.2%	51,452	$1.75M
71260	Computed tomography, thorax, diagnostic; with contrast material	1.1%	7,325	$1.67M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.1%	20,413	$1.59M
J9299	Injection, nivolumab, 1 mg	1.0%	353	$1.51M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	1.0%	54,857	$1.48M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	45,733	$1.44M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	45,714	$1.43M
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	38,104	$1.40M
93976		<1%	7,119	$1.36M
84443	Thyroid stimulating hormone (TSH)	<1%	105,294	$1.36M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	62,037	$1.33M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	22,389	$1.29M
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	10,875	$1.25M
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	1,505	$1.24M
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	52,860	$1.20M
90750		<1%	7,184	$1.18M
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,332	$1.17M
0360		<1%	10,866	$1.14M
80074		<1%	32,279	$1.10M
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	20,659	$1.03M
80048	Basic metabolic panel (calcium, ionized)	<1%	86,115	$1.03M
99499		<1%	25,086	$896K
J9271	Injection, pembrolizumab, 1 mg	<1%	242	$871K
83036	Hemoglobin; glycosylated (A1C)	<1%	125,131	$829K
0762		<1%	9,111	$810K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	16,655	$776K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	13,097	$770K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,747	$762K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	62,308	$761K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,936	$716K
80061	Lipid panel	<1%	99,959	$713K
J3490	Unclassified drugs	<1%	90,862	$709K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	588	$685K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	2,967	$681K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,485	$656K
86803		<1%	30,674	$651K
71046	Radiologic examination, chest; 2 views	<1%	35,146	$639K
83721		<1%	99,939	$634K
87581		<1%	10,876	$629K
87486		<1%	10,866	$628K
84484		<1%	34,497	$623K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	12,107	$620K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	10,802	$612K
0720		<1%	13,956	$605K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	27,275	$595K
99221		<1%	4,029	$594K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	6,266	$587K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	47,429	$558K
90715		<1%	16,446	$515K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	7,790	$507K
71250		<1%	2,694	$505K
90677		<1%	2,894	$496K
86780		<1%	66,149	$480K
T1014	Telehealth transmission, per minute, professional services bill separately	<1%	156,456	$480K
59025	Fetal non-stress test	<1%	26,173	$470K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	3,285	$452K
73221		<1%	1,250	$443K
72141		<1%	869	$442K
80076		<1%	35,552	$418K
96375	Therapeutic injection; each additional sequential IV push	<1%	11,284	$407K
99401		<1%	5,001	$378K
90651		<1%	3,233	$376K
Q5105	Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units	<1%	12,217	$376K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	184,603	$376K
70486		<1%	2,213	$366K
99402		<1%	5,286	$355K
83690		<1%	30,389	$341K
81001		<1%	82,286	$338K
93970		<1%	2,213	$334K
85027		<1%	55,299	$334K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	7,404	$333K
0710		<1%	12,558	$331K
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	3,839	$326K
97750		<1%	6,884	$316K
72132		<1%	2,256	$312K
70498		<1%	2,007	$301K
82948		<1%	56,372	$298K
93351		<1%	2,729	$298K
V2632	Posterior chamber intraocular lens	<1%	1,161	$297K
82805		<1%	5,674	$291K
72129		<1%	2,168	$290K
72126		<1%	2,077	$283K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	36,868	$282K
81025		<1%	48,149	$281K
76801		<1%	5,660	$272K
70491		<1%	1,293	$265K
90736		<1%	1,294	$265K
87040		<1%	8,236	$263K
93971		<1%	2,860	$262K
83605		<1%	12,807	$258K
90732		<1%	2,671	$255K
73630		<1%	10,866	$252K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	8,878	$246K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,611	$239K
73130		<1%	9,738	$239K
76642		<1%	3,867	$239K
G0378	Hospital observation service, per hour	<1%	4,299	$237K
Z9725		<1%	7,899	$235K
99231	Subsequent hospital care, per day, straightforward or low complexity	<1%	5,278	$232K
76770		<1%	3,604	$228K
73610		<1%	9,617	$227K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	13,611	$226K
99238	Hospital discharge day management, 30 minutes or less	<1%	8,326	$225K
73030		<1%	9,041	$223K
83735		<1%	29,331	$221K
83970		<1%	6,327	$218K
90670		<1%	3,515	$218K
83880		<1%	9,346	$215K
82803		<1%	6,828	$214K
82607		<1%	19,404	$213K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	3,697	$212K
71045	Radiologic examination, chest; single view	<1%	21,426	$208K
73110		<1%	8,936	$208K
72100		<1%	7,990	$207K
76830	Ultrasound, transvaginal	<1%	3,572	$199K
Z7610		<1%	30,272	$198K
85730		<1%	26,828	$197K
84439		<1%	24,360	$195K
82728		<1%	18,950	$194K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,214	$193K
85610		<1%	46,767	$191K
70496		<1%	1,104	$191K
77065	Tomosynthesis, mammo	<1%	2,285	$189K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	883	$182K
73564		<1%	6,582	$178K
97139		<1%	8,131	$172K
87086	Culture, bacterial; quantitative colony count, urine	<1%	27,199	$171K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,913	$164K
76813		<1%	2,331	$164K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	3,504	$164K
87522	Neg quan hep c or qual rna	<1%	3,674	$164K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	37,715	$152K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	5,396	$151K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	615	$149K
L2116	Ankle foot orthosis, fracture orthosis, tibial fracture orthosis, rigid, prefabricated, includes fitting and adjustment	<1%	269	$148K
66984	Extracapsular cataract removal with insertion of intraocular lens prosthesis	<1%	1,153	$146K
S3620	Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)	<1%	1,100	$146K
84100		<1%	31,439	$145K
90688		<1%	8,001	$143K
84702		<1%	10,974	$143K
86941		<1%	8,929	$143K
76536		<1%	2,957	$141K
90746		<1%	2,256	$140K
86850		<1%	16,432	$137K
L1980	Ankle foot orthosis, single upright free plantar dorsiflexion, solid stirrup, calf band/cuff (single bar 'bk' orthosis), custom fabricated	<1%	530	$132K
86480		<1%	5,359	$132K
93271		<1%	1,845	$129K
90678		<1%	717	$127K
77412		<1%	2,409	$125K
96361	Intravenous infusion, hydration; each additional hour	<1%	4,956	$124K
82570		<1%	38,549	$122K
99213	Doctor's office visit, returning patient (routine)	<1%	4,293	$122K
99284	Emergency room visit (serious)	<1%	1,456	$120K
96417		<1%	3,505	$120K
72110		<1%	2,786	$119K
94060		<1%	1,958	$115K
76870		<1%	2,114	$114K
J0897	Injection, denosumab, 1 mg	<1%	109	$113K
73590		<1%	5,882	$112K
74178		<1%	565	$112K
86901		<1%	19,358	$110K
81329		<1%	1,050	$109K
85379		<1%	7,379	$108K
99232	Hospital visit by a doctor, follow-up day	<1%	1,801	$107K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,296	$105K
72131		<1%	627	$103K
Q4081	Injection, epoetin alfa, 100 units (for esrd on dialysis)	<1%	12,144	$103K
99285	Emergency room visit (most serious)	<1%	528	$102K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	2,264	$102K
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	4,490	$102K
77336		<1%	2,527	$102K
96416		<1%	2,244	$99K
82550		<1%	9,489	$99K
67028	Intravitreal injection of a pharmacologic agent	<1%	2,330	$98K
0511		<1%	5,066	$98K
J7307	Etonogestrel (contraceptive) implant system, including implant and supplies	<1%	104	$97K
93017		<1%	1,929	$95K
95913		<1%	426	$95K
73700		<1%	460	$95K
97799		<1%	4,474	$93K
95911		<1%	1,141	$92K
73502		<1%	3,638	$91K
81003		<1%	35,641	$91K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,894	$90K
73080		<1%	3,776	$88K
73090		<1%	4,762	$88K
83550		<1%	15,151	$88K
J1756	Injection, iron sucrose, 1 mg	<1%	8,180	$87K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	2,181	$87K
73560		<1%	4,186	$86K
72040		<1%	3,709	$86K
0760		<1%	5,882	$86K
86900		<1%	21,042	$86K
87631		<1%	1,576	$85K
96415		<1%	3,188	$85K
97763		<1%	2,641	$85K
82746		<1%	7,850	$83K
81002		<1%	31,967	$82K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,591	$82K
77066	Tomosynthesis, mammo	<1%	800	$82K
83540		<1%	16,728	$80K
97039		<1%	3,582	$80K
87186		<1%	7,013	$79K
66982		<1%	458	$78K
73562		<1%	3,226	$78K
93308		<1%	1,175	$77K
99218		<1%	553	$76K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	2,098	$76K
88142		<1%	17,064	$75K
84153		<1%	5,858	$75K
84132		<1%	15,155	$75K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	1,936	$72K
92083		<1%	5,059	$69K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	983	$69K
L3808	Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment	<1%	454	$66K
93270		<1%	1,812	$65K
93226		<1%	1,331	$65K
71271		<1%	899	$64K
82043		<1%	16,689	$63K
86762		<1%	5,887	$62K
77387		<1%	313	$61K
92133		<1%	5,370	$61K
87340		<1%	7,382	$60K
86328		<1%	1,540	$60K
82274		<1%	13,168	$60K
88307		<1%	579	$59K
99203	Doctor's office visit, new patient (routine)	<1%	731	$59K
86920		<1%	738	$59K
76000		<1%	3,129	$59K
92235		<1%	768	$58K
77300		<1%	139	$58K
73620		<1%	3,059	$56K
94729		<1%	1,442	$56K
84295		<1%	8,788	$55K
73120		<1%	2,823	$55K
82435		<1%	8,664	$55K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	33,356	$54K
90585		<1%	783	$54K
20610		<1%	2,204	$54K
96367		<1%	1,529	$53K
73552		<1%	2,505	$51K
73600		<1%	2,578	$51K
J3489	Injection, zoledronic acid, 1 mg	<1%	1,543	$50K
84146		<1%	3,196	$50K
77080		<1%	1,812	$49K
93225		<1%	1,330	$48K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	2,456	$48K
86003		<1%	2,514	$48K
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	1,792	$48K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	347	$48K
73060		<1%	2,553	$47K
82378		<1%	2,595	$46K
85018		<1%	19,735	$46K
0515		<1%	15,953	$46K
83001		<1%	2,970	$45K
86141		<1%	6,429	$45K
90662		<1%	1,857	$44K
94726		<1%	1,061	$44K
73565		<1%	2,826	$44K
90671		<1%	935	$44K
71275	Computed tomographic angiography, chest, with contrast material	<1%	266	$44K
74174		<1%	137	$43K
90686		<1%	3,182	$42K
99214	Doctor's office visit, returning patient (more involved)	<1%	867	$42K
90707		<1%	1,619	$42K
73070		<1%	2,144	$42K
L3260	Surgical boot/shoe, each	<1%	493	$41K
86038		<1%	5,244	$41K
73100		<1%	2,344	$40K
83002		<1%	2,612	$40K
74018		<1%	2,468	$40K
70487		<1%	225	$40K
72072		<1%	1,296	$39K
83615		<1%	6,713	$39K
36415	Collection of venous blood by venipuncture	<1%	13,387	$38K
J1644	Injection, heparin sodium, per 1000 units	<1%	41,999	$38K
72170		<1%	2,080	$38K
93880		<1%	301	$37K
72050		<1%	994	$37K
87077		<1%	6,886	$37K
75574		<1%	198	$37K
86923		<1%	409	$36K
76604		<1%	840	$36K
90710		<1%	637	$35K
Q3014	Telehealth originating site facility fee	<1%	3,690	$35K
85384		<1%	3,303	$35K
97165		<1%	792	$34K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	1,272	$34K
82552		<1%	1,387	$34K
86140		<1%	7,265	$34K
99204	Doctor's office visit, new patient (more involved)	<1%	344	$34K
S0020	Injection, bupivicaine hydrochloride, 30 ml	<1%	3,528	$34K
82042		<1%	17,391	$34K
95886		<1%	1,228	$33K
99152		<1%	789	$33K
90380		<1%	76	$32K
94664		<1%	2,996	$32K
95816		<1%	322	$32K
86341		<1%	1,583	$32K
86706		<1%	2,429	$32K
J7030	Infusion, normal saline solution , 1000 cc	<1%	9,148	$32K
84480		<1%	2,372	$31K
90656		<1%	1,655	$30K
87902		<1%	729	$30K
G0444	Annual depression screening, 5 to 15 minutes	<1%	45,349	$30K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	8,736	$30K
87070		<1%	2,581	$30K
85652		<1%	11,680	$30K
J9190	Injection, fluorouracil, 500 mg	<1%	2,466	$29K
88304		<1%	1,377	$29K
87081		<1%	5,520	$29K
84481		<1%	2,761	$29K
90716		<1%	1,500	$29K
J2501	Injection, paricalcitol, 1 mcg	<1%	19,934	$28K
97802		<1%	874	$28K
87210		<1%	5,781	$27K
90734		<1%	1,381	$27K
86735		<1%	1,271	$27K
87536		<1%	661	$27K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	53	$26K
82105		<1%	3,904	$26K
84311		<1%	2,807	$26K
J7298	Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg	<1%	50	$26K
88312		<1%	1,656	$26K
84145		<1%	1,307	$26K
94660		<1%	584	$25K
Q9956	Injection, octafluoropropane microspheres, per ml	<1%	378	$25K
99217		<1%	971	$25K
82248		<1%	5,000	$25K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	850	$25K
90723		<1%	2,427	$25K
J2704	Injection, propofol, 10 mg	<1%	6,599	$25K
84550		<1%	6,751	$25K
97597		<1%	747	$25K
94799		<1%	233	$25K
87075		<1%	2,300	$24K
94375		<1%	1,174	$24K
72070		<1%	865	$24K
91200		<1%	1,202	$24K
90697		<1%	575	$24K
71101		<1%	627	$24K
73000		<1%	1,332	$24K
90649		<1%	243	$23K
93288		<1%	934	$23K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	813	$23K
73521		<1%	992	$23K
85007		<1%	6,910	$23K
88342		<1%	267	$22K
92134		<1%	2,016	$22K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	9,652	$22K
J1170	Injection, hydromorphone, up to 4 mg	<1%	4,476	$22K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	15,004	$21K
J7120	Ringers lactate infusion, up to 1000 cc	<1%	5,336	$21K
87338		<1%	3,809	$20K
73140		<1%	1,489	$20K
J8540	Dexamethasone, oral, 0.25 mg	<1%	12,525	$20K
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	1,816	$20K
99224		<1%	346	$20K
58100		<1%	849	$20K
82553		<1%	898	$19K
95909		<1%	324	$19K
97803		<1%	1,039	$19K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	1,077	$18K
10060		<1%	1,096	$18K
90633		<1%	2,067	$18K
84520		<1%	6,523	$17K
86235		<1%	969	$17K
94760		<1%	3,331	$17K
82040		<1%	4,569	$17K
83516		<1%	2,323	$16K
0983		<1%	1,759	$16K
11721		<1%	2,676	$16K
J0690	Injection, cefazolin sodium, 500 mg	<1%	4,744	$16K
73718		<1%	61	$16K
90658		<1%	1,488	$16K
90647		<1%	1,929	$16K
94010		<1%	297	$16K
J7050	Infusion, normal saline solution, 250 cc	<1%	21,234	$16K
82533		<1%	986	$16K
86431		<1%	3,761	$16K
49083		<1%	451	$16K
82951		<1%	1,981	$15K
80069		<1%	2,867	$15K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	1,933	$15K
90381		<1%	30	$15K
0270		<1%	2,905	$15K
29581		<1%	425	$15K
86580		<1%	3,468	$15K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	457	$15K
86304		<1%	1,793	$15K
82261		<1%	1,012	$14K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	5,514	$14K
86787		<1%	1,659	$14K
72128		<1%	100	$14K
88141		<1%	3,579	$14K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	830	$14K
74170		<1%	72	$14K
12001		<1%	946	$14K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	1,260	$14K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	221	$14K
72082		<1%	374	$14K
S0077	Injection, clindamycin phosphate, 300 mg	<1%	1,258	$14K
84402		<1%	1,088	$13K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	1,817	$13K
82565		<1%	4,625	$13K
84134		<1%	1,145	$13K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	703	$13K
90632		<1%	309	$13K
90654		<1%	706	$13K
99404		<1%	165	$13K
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	935	$13K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	167	$13K
86592		<1%	3,302	$12K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	252	$12K
83020		<1%	927	$12K
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	1,234	$12K
C1874	Stent, coated/covered, with delivery system	<1%	12	$12K
93283		<1%	248	$12K
J7060	5% dextrose/water (500 ml = 1 unit)	<1%	6,358	$12K
84403		<1%	3,154	$12K
0512		<1%	467	$12K
87205		<1%	2,116	$12K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	149	$12K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	741	$11K
86255		<1%	1,596	$11K
99225		<1%	192	$11K
84140		<1%	388	$11K
92700		<1%	68	$11K
86360		<1%	293	$11K
71020		<1%	427	$10K
J1750	Injection, iron dextran, 50 mg	<1%	95	$10K
80179		<1%	717	$10K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	14,786	$10K
86160		<1%	1,286	$10K
85014		<1%	6,221	$10K
90681		<1%	1,076	$10K
76882		<1%	970	$10K
77003		<1%	292	$9K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	79	$9K
G0008	Administration of influenza virus vaccine	<1%	1,577	$9K
86593		<1%	1,857	$9K
94750		<1%	486	$9K
82140		<1%	496	$9K
84156		<1%	5,154	$9K
80051		<1%	2,416	$9K
82985		<1%	731	$9K
93454		<1%	13	$9K
82962		<1%	2,736	$9K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	160	$9K
99153	Mod sedat endo service >5yrs	<1%	525	$8K
82784		<1%	1,484	$8K
G0009	Administration of pneumococcal vaccine	<1%	1,259	$8K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,026	$8K
12002		<1%	568	$8K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	171	$8K
74220		<1%	224	$8K
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,060	$8K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	6,861	$8K
99000		<1%	2,025	$8K
88341		<1%	99	$8K
96411		<1%	400	$8K
0517		<1%	45,543	$8K
77295		<1%	12	$8K
76519		<1%	175	$8K
G8431	Screening for depression is documented as being positive and a follow-up plan is documented	<1%	3,926	$8K
86039		<1%	1,266	$8K
90700		<1%	939	$8K
80164		<1%	674	$8K
J1815	Injection, insulin, per 5 units	<1%	1,815	$7K
85045		<1%	2,939	$7K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	2,812	$7K
87147		<1%	1,837	$7K
86225		<1%	891	$7K
29700		<1%	683	$7K
94727		<1%	278	$7K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	16,241	$7K
84681		<1%	1,412	$7K
G8433	Screening for depression not completed, documented patient or medical reason	<1%	5,048	$7K
11750		<1%	180	$6K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	614	$6K
86200		<1%	2,658	$6K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	4,666	$6K
74183		<1%	25	$6K
90648		<1%	623	$6K
77334		<1%	26	$6K
36600		<1%	987	$6K
90791	Psychiatric diagnostic evaluation	<1%	164	$6K
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	<1%	4,562	$6K
96402		<1%	600	$6K
29125		<1%	986	$6K
12011		<1%	275	$6K
95819		<1%	158	$6K
87088		<1%	1,132	$6K
82947		<1%	3,118	$6K
84436		<1%	618	$6K
90832	Psychotherapy session, about 30 minutes	<1%	737	$5K
73200		<1%	26	$5K
81596		<1%	238	$5K
85651		<1%	2,379	$5K
84445		<1%	223	$5K
77417		<1%	85	$5K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	434	$5K
82670		<1%	731	$5K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	752	$5K
95912		<1%	51	$5K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	3,495	$5K
86317		<1%	1,655	$5K
86376		<1%	1,601	$5K
29075		<1%	1,155	$5K
L0140	Cervical, semi-rigid, adjustable (plastic collar)	<1%	87	$5K
86300		<1%	860	$5K
70360		<1%	316	$5K
90696		<1%	534	$4K
69210		<1%	875	$4K
74022		<1%	106	$4K
72220		<1%	187	$4K
86765		<1%	1,303	$4K
96409		<1%	249	$4K
86800		<1%	780	$4K
86256		<1%	404	$4K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	3,613	$4K
93282		<1%	99	$4K
64635		<1%	39	$4K
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	320	$4K
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	6,746	$4K
82247		<1%	862	$4K
95885		<1%	141	$4K
72083		<1%	84	$4K
76706		<1%	88	$4K
72197		<1%	13	$4K
57454		<1%	169	$3K
90680		<1%	404	$3K
G0202	Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed	<1%	44	$3K
52000		<1%	57	$3K
84154		<1%	662	$3K
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	318	$3K
70320		<1%	98	$3K
83520		<1%	269	$3K
J0694	Injection, cefoxitin sodium, 1 gm	<1%	350	$3K
82375		<1%	266	$3K
86677		<1%	149	$3K
82310		<1%	971	$3K
86696		<1%	496	$3K
62323		<1%	70	$3K
J2060	Injection, lorazepam, 2 mg	<1%	2,270	$3K
S0164	Injection, pantoprazole sodium, 40 mg	<1%	290	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	1,323	$3K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	380	$3K
86709		<1%	151	$3K
82150		<1%	506	$3K
51702		<1%	352	$3K
84300		<1%	600	$3K
87517		<1%	100	$3K
69209		<1%	497	$3K
83935		<1%	416	$3K
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	<1%	12	$3K
97162		<1%	128	$3K
84165		<1%	389	$3K
87641		<1%	123	$3K
86708		<1%	186	$3K
L3929	Hand finger orthosis, includes one or more nontorsion joint(s), turnbuckles, elastic bands/springs, may include soft interface material, straps, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise	<1%	39	$3K
99199	Unlisted special service, procedure or report	<1%	56	$3K
J2785	Injection, regadenoson, 0.1 mg	<1%	90	$3K
84425		<1%	209	$3K
58300		<1%	378	$3K
73020		<1%	110	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	24	$2K
82652		<1%	839	$2K
72080		<1%	90	$2K
Z7514		<1%	41	$2K
86695		<1%	524	$2K
29085		<1%	357	$2K
76516		<1%	67	$2K
82088		<1%	249	$2K
43235		<1%	74	$2K
J0780	Injection, prochlorperazine, up to 10 mg	<1%	508	$2K
90733		<1%	29	$2K
93975		<1%	14	$2K
93923		<1%	25	$2K
83930		<1%	287	$2K
11055		<1%	828	$2K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	233	$2K
45382		<1%	37	$2K
87901		<1%	126	$2K
20550		<1%	201	$2K
83090		<1%	429	$2K
90682		<1%	66	$2K
74240		<1%	40	$2K
90685		<1%	202	$2K
36592		<1%	85	$2K
36430		<1%	73	$2K
88173		<1%	174	$2K
83050		<1%	266	$2K
86704		<1%	514	$2K
J0461	Injection, atropine sulfate, 0.01 mg	<1%	623	$2K
99385		<1%	16	$2K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	37	$2K
10005		<1%	58	$2K
76820		<1%	104	$2K
90620		<1%	131	$2K
29515		<1%	253	$2K
84270		<1%	133	$2K
94618		<1%	64	$2K
83655		<1%	159	$2K
51798		<1%	194	$2K
86146		<1%	55	$2K
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	2,208	$2K
92250		<1%	115	$2K
82950		<1%	1,064	$2K
J9171	Injection, docetaxel, 1 mg	<1%	25	$2K
87045		<1%	214	$2K
J0735	Injection, clonidine hydrochloride, 1 mg	<1%	189	$2K
78306		<1%	12	$1K
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	<1%	3,776	$1K
93289		<1%	36	$1K
93280		<1%	145	$1K
86015		<1%	332	$1K
29065		<1%	422	$1K
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	517	$1K
82785		<1%	488	$1K
91320		<1%	30	$1K
J9045	Injection, carboplatin, 50 mg	<1%	71	$1K
88112		<1%	98	$1K
29405		<1%	155	$1K
76942		<1%	26	$1K
J9267	Injection, paclitaxel, 1 mg	<1%	72	$1K
86769		<1%	32	$1K
82024		<1%	284	$1K
G9578	Documentation of signed opioid treatment agreement at least once during opioid therapy	<1%	1,291	$1K
77290		<1%	12	$1K
86702		<1%	110	$1K
84244		<1%	239	$1K
64636		<1%	25	$1K
G0010	Administration of hepatitis b vaccine	<1%	103	$1K
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	116	$1K
76001		<1%	16	$1K
J1940	Injection, furosemide, up to 20 mg	<1%	695	$1K
J7999	Compounded drug, not otherwise classified	<1%	79	$1K
71010		<1%	85	$1K
99383		<1%	14	$1K
86334		<1%	72	$1K
86701		<1%	110	$1K
82977		<1%	128	$1K
90739		<1%	14	$1K
11720		<1%	339	$1K
93041		<1%	92	$1K
84133		<1%	196	$1K
86361		<1%	95	$1K
90713		<1%	114	$1K
84155		<1%	347	$1K
A9581	Injection, gadoxetate disodium, 1 ml	<1%	92	$1K
99382		<1%	15	$1K
82627		<1%	302	$1K
76775		<1%	14	$975.39
93284		<1%	19	$968.42
84478		<1%	256	$950.09
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	248	$936.94
98926		<1%	50	$935.03
L3763	Elbow wrist hand orthosis, rigid, without joints, may include soft interface, straps, custom fabricated, includes fitting and adjustment	<1%	27	$909.12
85732		<1%	161	$868.01
83883		<1%	29	$864.83
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	<1%	18	$807.75
90834	Psychotherapy session, about 45 minutes	<1%	312	$805.92
90619		<1%	43	$797.66
29105		<1%	112	$790.47
66821		<1%	28	$778.55
95910		<1%	12	$760.50
11200		<1%	97	$753.60
87625		<1%	55	$744.84
70355		<1%	31	$733.44
J1630	Injection, haloperidol, up to 5 mg	<1%	480	$728.20
93042		<1%	39	$725.21
96368		<1%	37	$718.50
84207		<1%	93	$711.52
87046		<1%	215	$706.03
92081		<1%	16	$693.68
76512		<1%	13	$691.79
95907		<1%	19	$661.64
G8484	Influenza immunization was not administered, reason not given	<1%	2,826	$656.20
74420		<1%	14	$656.06
83521		<1%	27	$653.62
90744		<1%	68	$652.96
11056		<1%	397	$644.96
83021		<1%	107	$592.72
J1953	Injection, levetiracetam, 10 mg	<1%	141	$569.53
82103		<1%	175	$566.57
86705		<1%	53	$564.96
86021		<1%	47	$555.06
29705		<1%	164	$517.92
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	38	$475.62
0250		<1%	1,252	$464.77
83835		<1%	49	$460.40
16020		<1%	58	$432.70
3080F		<1%	28,551	$428.12
20605		<1%	16	$422.23
84432		<1%	70	$421.06
92136		<1%	13	$417.41
89051		<1%	41	$416.15
86147		<1%	69	$410.42
85041		<1%	276	$410.17
82465		<1%	149	$407.72
J0290	Injection, ampicillin sodium, 500 mg	<1%	161	$392.47
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	165	$377.30
70300		<1%	56	$371.51
82436		<1%	56	$370.42
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	77	$343.70
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	208	$340.51
Z7512		<1%	13	$339.69
J0456	Injection, azithromycin, 500 mg	<1%	124	$339.66
96160		<1%	431	$336.99
86301		<1%	55	$296.89
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	179	$283.08
J0571	Buprenorphine, oral, 1 mg	<1%	25	$279.46
82542		<1%	13	$275.56
20553		<1%	13	$255.03
97161		<1%	12	$252.48
84255		<1%	12	$248.50
31575		<1%	13	$240.00
J3360	Injection, diazepam, up to 5 mg	<1%	72	$234.43
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	182	$220.49
1036F		<1%	269,270	$216.64
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	20	$213.06
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	<1%	16	$207.48
82270		<1%	282	$189.34
92551		<1%	12	$175.56
G9579	No documentation of signed an opioid treatment agreement at least once during opioid therapy	<1%	100	$173.25
80178		<1%	93	$170.66
84144		<1%	42	$168.00
85460		<1%	13	$156.47
J7042	5% dextrose/normal saline (500 ml = 1 unit)	<1%	81	$156.40
3061F		<1%	13,247	$154.43
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	616	$149.16
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	133	$146.59
88302		<1%	25	$145.26
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	19	$145.09
85008		<1%	38	$144.62
83498		<1%	26	$144.30
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	<1%	25	$136.36
3074F		<1%	189,309	$136.34
82672		<1%	26	$133.80
11981		<1%	12	$126.00
11730		<1%	12	$126.00
82390		<1%	114	$122.08
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	698	$119.49
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	214	$118.83
3052F		<1%	10,577	$116.47
80197		<1%	14	$113.23
83525		<1%	12	$112.55
84466		<1%	26	$112.12
83993		<1%	14	$109.92
3077F		<1%	62,494	$105.45
58301		<1%	14	$97.52
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	15	$96.95
87177		<1%	16	$87.00
87209		<1%	16	$87.00
84450		<1%	13	$86.31
84540		<1%	13	$85.20
86812		<1%	13	$82.20
87400		<1%	13	$75.27
17340		<1%	25	$75.00
84630		<1%	26	$73.92
J1580	Injection, garamycin, gentamicin, up to 80 mg	<1%	13	$68.77
C9257	Injection, bevacizumab, 0.25 mg	<1%	13	$67.19
84590		<1%	14	$62.92
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	124	$60.30
3078F		<1%	181,420	$42.94
3048F		<1%	34,364	$42.94
J1790	Injection, droperidol, up to 5 mg	<1%	41	$37.60
J3480	Injection, potassium chloride, per 2 meq	<1%	29	$34.72
3075F		<1%	55,410	$33.03
90480		<1%	15	$31.46
83986		<1%	104	$26.10
89055		<1%	14	$23.87
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	13	$23.28
4004F		<1%	10,110	$22.45
G0442	Annual alcohol misuse screening, 5 to 15 minutes	<1%	138	$20.76
83519		<1%	16	$14.94
90472	Immunization administration, each additional vaccine (list separately)	<1%	370	$13.21
3044F		<1%	109,258	$12.93
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	1,775	$10.00
G8483	Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons)	<1%	1,013	$5.00
90378		<1%	13	$3.25
3046F		0%	16,553	$0.00
G8482	Influenza immunization administered or previously received	0%	424	$0.00
3050F		0%	18,365	$0.00
3051F		0%	15,108	$0.00
G0476	Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test	0%	455	$0.00
80321		0%	75	$0.00
3045F		0%	263	$0.00
95004	Percutaneous tests with allergenic extracts, immediate type reaction	0%	27	$0.00
G8511	Screening for depression documented as positive, follow-up plan not documented, reason not given	0%	1,468	$0.00
3062F		0%	445	$0.00
90837	Psychotherapy session, about an hour	0%	51	$0.00
0272		0%	13	$0.00
2028F		0%	25	$0.00
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	0%	12	$0.00
80361		0%	13	$0.00
0031A		0%	34	$0.00
3060F		0%	6,875	$0.00
3079F		0%	91,774	$0.00
H0049	Alcohol and/or drug screening	0%	345	$0.00
3351F		0%	179	$0.00
H0001	Alcohol and/or drug assessment	0%	1,387	$0.00
80363		0%	95	$0.00
G9012	Other specified case management service not elsewhere classified	0%	19	$0.00
Q4051	Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies)	0%	16	$0.00
81599		0%	13	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHALLER, COLENE (CHIEF OPERATING OFFICER)

Same official

Other billing entities under HALLER, COLENE

Full network →

Provider	Location	Paid
Arrowhead Regional Medical Center	Colton, CA	$172K
Arrowhead Regional Medical Center	Colton, CA	$0.00

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.